Alyeska Investment Group, L.P.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1453072
CHICAGO, IL
Position in TEVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$166,233,183
+$55,875,809 QoQ
Shares Held
5,519,030
+56.1% QoQ
Ownership
0.474%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Alyeska Investment Group, L.P. holds $190,720,824 across 3 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (87.2% of the industry book) .
All Filings in TEVA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $166,233,183 | 5,519,030 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $110,357,374 | 3,535,962 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $120,715,907 | 5,976,035 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $40,734,476 | 2,430,458 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $49,577,671 | 3,225,613 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $80,256,279 | 3,641,392 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $65,322,500 | 3,625,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $62,219,153 | 3,828,871 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $89,539,350 | 6,345,808 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $56,995,185 | 5,459,309 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $65,918,275 | 6,462,576 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,295,000 | 1,500,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,080,000 | 800,000 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||